As Pfizer’s Chief Patient Officer, Dr. Freda Lewis-Hall’s vision of patient-centricity is to serve patients around the world by seeking their voice and input, as well as understanding and responding to their needs. Biopharmaceutical companies can leverage its their resources to put patients first by advocating on behalf of patients who are counting on the delivery of innovative medicines and vaccines. To fulfill this mission, Dr. Lewis-Hall takes a multi-pronged approach, which centers on the following principles:
- Deepen insight into patient needs to ensure that the patient voice is thoroughly embedded in research and development
- Target gender, age, and race inequities in our health system to help patients’ access medicines
- Extend the reach of health information and education initiatives to improve public health literacy
- Galvanize thousands of employees to become individual ‘Chief Patient Officers’ in their own right
Executive Vice President and Chief Patient Officer
Health care stakeholders are in the midst of radical change, with a shift to value-based care and an increase in stakeholder consolidations and acquisitions. In addition to increased vertical integration, other disruptors are moving into health care, such as Amazon with its vision to reshape the way prescription drugs are delivered. Yet, amidst all of this change, these constants remain: organizations must focus managing costs, improving quality of care, and enhancing the patient experience. For pharmaceutical companies to ensure patients are at the center of their organization’s strategy, they must understand and adapt to this changing marketplace, meet the needs of their customers in the move to value-based care, be a valued partner in ensuring care coordination and improved patient experiences.
- Explore current merger and acquisition trends to adjust care delivery and payment strategies
- Identify changing stakeholder needs and incentives when developing partnerships with payers, providers, PBMs, and advocacy groups
- Examine how changes in health care delivery are creating new opportunities for collaboration to improve patient outcomes
Chief Executive Officer
National Coalition on HealthCare
Vice President, Patient Engagement & Chief Experience Officer
Holy Name Medical Center
In July 2018, CMS released a memo to Medicare Part D plans explaining CMS’s expectations regarding formulary exception requests. The memo also provided tools to plans to ensure that beneficiaries utilize low-cost generics when available on formulary and designed drug dashboards to ensure drug pricing transparency. As CMS continues to move health care toward greater implementation of value-based care and patient affordability, stakeholders must align organizational strategies to focus on quality. Explore recent changes to Medicare Part D, population health initiatives, and future CMS priorities for value-based care.
- Gain a high-level overview of the recently release Medicare Part D changes
- Learn about CMS efforts to improve population health and quality of care
- Discuss the implications of future CMS priorities on all stakeholders
Chief Medical Officer
Patients and caregivers can deliver insights that are crucial to the advancement of new therapies, market access, patient advocacy, and adherence. It is critical to map the patient journey to overcome roadblocks faced along the continuum of care. Ensuring patient-centricity isn’t just a buzzword requires manufacturers and key stakeholders to put themselves in the shoes of their patients. Hear directly from patients about their experiences with commercial and rare disease therapies, how they navigate the health care system, and where opportunities exist to elevate the patient voice within your organization’s strategies.
- Gain insight into the real-life struggles of patients and caregivers
- Explore best practices when implementing patient support services
- Understand how to build interventions that improve adherence, foster advocacy collaborations, and advance market access
Executive Director, Board Chairman, American Living Organ Donor Fund;
Patient Advisor, PCORI Ambassador;
The market access, pricing, and reimbursement landscape is rapidly evolving as stakeholders shift to a value-based health care system. The high price of some pharmaceuticals has made it difficult for patients to afford and access their medications, increasing the likelihood of non-adherence, discontinuation of therapy, and soaring out-of-pocket costs. Health plans and PBMs are using utilization management practices such as prior authorizations or step therapy to manage the cost of drugs to the system. At the same time, co-pay assistance and other patient support programs are used to help make prescriptions more affordable to patients. In order to improve the patient experience, stakeholders must collaborate and develop strategies to ensure patient access and overcome affordability challenges.
- Understand how to design effective patient access and assistance programs
- Discuss the implications of copay and coupon use on patient access
- Gain insight into patient decision making to identify where opportunities to provide additional support may exist
- Discuss ways stakeholders can improve collaboration to ensure access to necessary medicines
Promidian, an EVERSANA company
Vice President, Global Patient Centered Outcomes and Solutions
Social factors such as education, income, nutrition, and access to housing impacts an individual’s ability to access health care. Interventions developed collaboratively with a variety of stakeholders are paving the way to address such disparities at the community level. With a greater focus on looking at the “whole person” and not simply considering individuals as “patients,” some manufacturers are collaborating with stakeholders to develop social support interventions that help patients’ access health care. Using SDOH data can be a first step to better understand barriers to managing diseases and align the right community resources. Explore how Novo Nordisk implemented the “Cities Changing Diabetes” project to address the social determinants of health and overcome barriers for those populations at-risk for diabetes.
- Leverage SDOH data to gain insight into the patient experience and identify barriers to adherence
- Engage community partners to develop local interventions to improve patient adherence and engagement
- Drive site-of-care coordination
- Understand the current trends in social determinants of health
A person’s ability to make appropriate health decisions relies on their capacity to understand health information, services, and prescriptions. Health literacy is critical to self-management of health conditions, effectively navigating the health system, and understanding the benefits and safe use of a medication at the point of prescription. Providers, pharmacists, pharmaceutical companies, payers, and advocacy groups have the opportunity to improve health literacy and patient education by developing patient education tools with health literacy in mind. In this session, explore how to build a health-literacy approach to overcome adherence barriers.
- Examine a variety of health literacy tools, such as standardized prescription medicine instructions, medication action plans to support provider and patient communication, and health information materials
- Develop tools and solutions to improve communication between patients, pharmacists, and providers
- Create health literacy and education materials to assist in medication management
Vice President, Global Population Health
Merck & Co, Inc.
Patients coping with a chronic condition must overcome short-term challenges in daily life in order to have positive long-term health outcomes. Issues with treatment complexity and adherence often form barriers to success. Manufacturers can identify these challenges by supporting patients after launch to provide a richer understanding of a new therapy impacts daily life. These patient experiences provide important insights on how partnerships can be developed for long-term success.
- Review a case study where nurse educators support patients initiating a new cancer treatment
- Understand how communication gaps between patient and physician create barriers to long-term success
- Partner with patients to improve long-term health outcomes
Manufacturers have the opportunity to leverage adherence information as part of their product value story by collecting economic and clinical data to justify reimbursement, as payers put additional focus on patient outcomes to manage the overall cost of care. Manufacturers can learn from payers with successful adherence interventions, as well as collaborate on initiatives to improve their programs’ success rates. Explore case examples of successful payer adherence interventions and opportunities for collaboration.
- Gain insights directly from health plans on what they consider to be reliable systems and metrics for measuring the effectiveness of an adherence program
- Leverage payer insights to update reimbursement strategies, ensure better patient access, and optimize patient outcomes
- Explore opportunities for industry partnerships to collaborate on adherence programs
- Discuss how value-based payment models are being designed to reward adherence, persistency, quality, and efficiency outcomes
Medical Director, California Medi-Cal
Anthem Blue Cross
Chief Health Innovation Officer
Executive Medical Director, Population Health
Horizon Blue Cross Blue Shield of New Jersey
Providers play a crucial role in a patient’s treatment journey. Studies have shown that improving patient-provider relationships can improve medication adherence and support a more positive patient experience. Hospitals, Health Systems, ACOs, and IDNs have implemented programs to address adherence, population health, and quality with the goal of improving health outcomes. Manufacturers can collaborate with these provider organizations to offer integrated therapy management programs that overcome barriers to adherence and improve the patient experience.
- Increase engagement in adherence programs through the physician-patient interaction
- Align support programs to deliver patient-centered care for optimal engagement and program scalability across patient populations